Our history
Pioneering Analytic Technologies
Navinci (formerly Olink Bioscience), has a proud history of inventing analytic technologies for nucleic acids and proteins, identifying commercial opportunities and bringing successful products to the market to serve scientist in research and drug development. First founded in 2004 on the breakthrough innovations by Professor Ulf Landegren and colleagues at Uppsala University, the company has directly marketed a wide range of products including the Duolink in situ protein detection product line, which was acquired by Sigma-Aldrich in 2016, and Proseek multiplex panels now known as Olink Target and marketed by Olink Proteomics.
In 2016, Olink Proteomics was spun out and Olink BioScience became Navinci Diagnostics. Olink Proteomics has rapidly become the world-leader of high-multiplex biomarker analysis in circulation to improve precision medicine and was recently aquired by Thermo Fisher Scientific.
Advancing Spatial Biology with Uppsala University
Navinci has in close collaboration with Uppsala University continued to innovate the field of spatial biology with groundbreaking tools for studies of the tissue microenvironment.
Revolutionizing in situ Proximity Ligation Assay Techniques
In 2020, Navinci launched the next generation of in situ proximity ligation assay techniques, our proprietary UnFold technology, to scientists worldwide in the NaveniFlex product line. We are now rapidly expanding our offering for in situ detection of protein interactions and post-translational modifications, not possible with standard techniques such as ImmunoFluorescence and ImmunoHistoChemistry.